Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer

Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer

PurposeTo explore the predictive value of multiple immune-inflammatory biomarkers including serum VEGFA and systemic immune-inflammation index (SII) in HER2-negative advanced gastric cancer (AGC) and establish nomograms for predicting the first-line chemotherapeutic efficacy, progression-free surviv...

Full description

Bibliographic Details
Main Authors:	Yan Yang, Yu Shao, Junjun Wang, Qianqian Cheng, Hanqi Yang, Yulong Li, Jing Liu, Yangyang Zhou, Zhengguang Zhou, Mingxi Wang, Baoan Ji, Jinghao Yao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Oncology
Subjects:	nomogram predictive model VEGFA HER2-negative advanced gastric cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1185240/full

Similar Items

Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study
by: Yuqi Sun, et al.
Published: (2023-04-01)

18F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value
by: Jin Suk Kim, et al.
Published: (2014-05-01)

A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer
by: Wei Wang, et al.
Published: (2018-05-01)

Development and external validation of a radiomics model for assessment of HER2 positivity in men and women presenting with gastric cancer
by: Huiping Zhao, et al.
Published: (2023-02-01)

A Novel Prognostic Nomogram for Predicting Survival of Hormone Receptor-Positive and HER2 Negative Advanced Breast Cancer Among the Han-Population
by: Yimin Zhu, et al.
Published: (2022-07-01)

Development and Validation of Prognostic Nomogram Based on Negative Lymph Node Count for Patients with Gastric Signet Ring Cell Carcinoma
by: LI Jinzhou, et al.
Published: (2022-09-01)

Nomogram for predicting pathological response to neoadjuvant treatment in patients with locally advanced gastric cancer: Data from a phase III clinical trial
by: Han Shao, et al.
Published: (2024-03-01)

Evaluation of Epidermal Growth Factor Receptor 2 Status in Gastric Cancer by CT-Based Deep Learning Radiomics Nomogram
by: Xiao Guan, et al.
Published: (2022-07-01)

The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram
by: Shuxing Wang, et al.
Published: (2021-10-01)

Challenges and future of HER2-positive gastric cancer therapy
by: Chenzhe Ma, et al.
Published: (2023-01-01)

Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab
by: Sebastian Schade, et al.
Published: (2022-02-01)

Radiomics Nomogram for Prediction of Peritoneal Metastasis in Patients With Gastric Cancer
by: Weicai Huang, et al.
Published: (2020-08-01)

Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients
by: Guo-dong Cao, et al.
Published: (2017-12-01)

A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study
by: Yanfen Cui, et al.
Published: (2022-04-01)

Developing and validating nomograms for predicting the survival in patients with clinical local-advanced gastric cancer
by: Chong Hou, et al.
Published: (2022-10-01)

Role of HER2neu expression in gastric cancer
by: J S Sukanya, et al.
Published: (2021-01-01)

A Novel Hematological Inflammation-Nutrition Score (HINS) and Its Related Nomogram Model to Predict Survival Outcome in Advanced Gastric Cancer Patients Receiving First-Line Palliative Chemotherapy
by: Chen C, et al.
Published: (2023-07-01)

A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological study
by: Huimin Zhang, et al.
Published: (2019-05-01)

A nomogram for predicting the HER2 status of circulating tumor cells and survival analysis in HER2-negative breast cancer
by: Yuqin Yang, et al.
Published: (2022-12-01)

A Practical Nomogram for Predicting the Prognosis of Elderly Patients with Gastric Adenocarcinoma After Gastrectomy
by: Yang H, et al.
Published: (2022-01-01)

Prognostic and clinical significance of HER-2 low expression in early-stage gastric cancer
by: Tao Yang, et al.
Published: (2022-11-01)

From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer
by: Sun J, et al.
Published: (2022-07-01)

Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection
by: Yi He, et al.
Published: (2019-03-01)

Fibrinogen-to-Lymphocyte Ratio Was an Independent Predictor of Lymph Node Metastasis in Patients with Clinically Node-Negative Advanced-Stage Gastric Cancer
by: Hu P, et al.
Published: (2023-04-01)

M2 Macrophage-Based Prognostic Nomogram for Gastric Cancer After Surgical Resection
by: Jianwen Hu, et al.
Published: (2021-08-01)

Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions
by: Hongsik Kim, et al.
Published: (2019-09-01)

Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma
by: Aqiao Xu, et al.
Published: (2022-08-01)

The full management from first-line to third-line treatments in patients with Her-2–negative advanced gastric cancer
by: Chunxiao Chang, et al.
Published: (2022-11-01)

History and Future of HER2-Targeted Therapy for Advanced Gastric Cancer
by: Shin Ariga
Published: (2023-05-01)

Development and validation of a nomogram to individually predict survival of young patients with nonmetastatic gastric cancer: A retrospective cohort study
by: Chaorui Wu, et al.
Published: (2019-01-01)

Survival nomogram for different grades of gastric cancer patients based on SEER database and external validation cohort
by: Lei Hu, et al.
Published: (2022-09-01)

A Nomogram for Predicting Risk of Thromboembolism in Gastric Cancer Patients Receiving Chemotherapy
by: Hai-Liang Yuan, et al.
Published: (2021-05-01)

A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage IB gastric adenocarcinoma
by: Yangyang Xie, et al.
Published: (2023-03-01)

The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells
by: Li-Fei Sun, et al.
Published: (2020-08-01)

Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study
by: Tong G, et al.
Published: (2020-04-01)

Polyethylene glycol-conjugated HER2-targeted peptides as a nuclear imaging probe for HER2-overexpressed gastric cancer detection in vivo
by: Siao-Syun Guan, et al.
Published: (2018-06-01)

Application value of nomogram and prognostic factors of gastric cancer patients who underwent D2 radical lymphadenectomy
by: Guang-Chuan Mu, et al.
Published: (2019-11-01)

Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy
by: Tai Ma, et al.
Published: (2019-08-01)

Significant effect of posterior line treatment of HER2 positive advanced gastric cancer: A case report
by: Xiaoting Ma, et al.
Published: (2024-04-01)

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
by: Chen Xu, et al.
Published: (2017-05-01)